BERKELEY, CA (UroToday.com) - The premise of this study was derived from the recent National Institutes of Health State-of-the-Science conference on the Role of Active Surveillance in the Management of Men with Localized Prostate Cancer.[1]
Prostate needle biopsy (PNBx) is essential for prostate cancer diagnosis, yet it is not without risks. We sought to assess patients who underwent PNBx using a claims-based frailty index (CFI) to study the association between frailty and post-biopsy complications from a large population-based cohort.
SAN DIEGO, CA USA (UroToday.com) - With rising rates of cross-sectional imaging, incidental renal mass often presents a clinical challenge, especially in the elderly and infirm.
SAN DIEGO, CA USA (UroToday.com) - As the elderly population in the U.S. continues to dramatically increase, urologists are faced with unique management dilemmas for those patients requiring surgery.
BERKELEY, CA (UroToday.com) - Age is a risk factor for the occurrence of bladder cancer and bladder cancer is a disease of the elderly.
BERKELEY, CA (UroToday.com) - There are few studies estimating the prevalence of urinary incontinence (UI) in poor populations.
ORLANDO, FL, USA (UroToday.com) - As a counterpoint, Dr. Alexander Kutikov from Fox Chase Cancer Center in Philadelphia was making the case for radical nephrectomy (RN) in elderly patients.
ORLANDO, FL, USA (UroToday.com) - In this session, Dr. John L. Gore of the University of Washington School of Medicine in Seattle was making the case for partial nephrectomy (PN) in elderly patients.
ORLANDO, FL, USA (UroToday.com) - The Phase 3 IMPACT study showed significant improvement in overall survival with sipuleucel-T immunotherapy. The PROCEED trial is an ongoing Phase 4 registry enrolling patients receiving sipuleucel-T in the real-world setting. Enrollment has no restriction on whether docetaxel has been used to treat.
ORLANDO, FL, USA (UroToday.com) - Sipuleucel-T is an autologous cellular immunotherapy approved for the treatment of men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)...Click here to enlarge and view the poster.
CHICAGO, IL USA (UroToday.com) - This was an interesting poster as it described the impact of a telemonitoring system (mobile SIM assistive device) on UI care for older persons, with dementia, living in nursing homes.
BERKELEY, CA (UroToday.com) - It is clear that medication-related problems such as the frequency of missing a dose of medication, inaccurate dosages, and incorrect route of administration are very common in people with chronic illness.
When seeking treatment for male SUI (mSUI), patients are faced with weighing complex risks and benefits in making treatment decisions within their individual context. We sought to quantify the frequency of decisional regret among this population and to determine factors associated with regret.
Login to update email address, newsletter preferences and use bookmarks.
Email
Password